Susan Galbraith

Susan Galbraith

Corporate Officer/Principal presso ASTRAZENECA PLC
Consumer Services
Health Technology
Finance

Profilo

Susan Mary Galbraith is currently Executive VP-Oncology Research & Development at AstraZeneca PLC since 2021, with employment at AstraZeneca PLC starting in 2010.
Former roles include Director at the American Association for Cancer Research from 2021 to 2024, Member-Supervisory Board at BB Biotech AG from 2020 to 2021, Independent Non-Executive Director at Horizon Discovery Group Ltd. from 2014 to 2020, and Vice President-Oncology & Clinical Biomarkers at Bristol-Myers Squibb Pharmaceuticals Ltd. in 2010.
Education includes undergraduate studies at The University of Manchester, graduate studies at the University of Cambridge, and a doctorate from the University of London.

Posizioni attive di Susan Galbraith

SocietàPosizioneInizio
ASTRAZENECA PLC Corporate Officer/Principal 01/01/2010

Precedenti posizioni note di Susan Galbraith

SocietàPosizioneFine
Direttore/Membro del Consiglio 01/01/2024
BB BIOTECH AG Direttore/Membro del Consiglio 02/07/2021
HORIZON DISCOVERY GROUP PLC Direttore/Membro del Consiglio 30/04/2020
Corporate Officer/Principal 01/01/2010
Vedi nel dettaglio l'esperienza di Susan Galbraith

Formazione di Susan Galbraith

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

83

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Finance

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Distribution Services

  1. Mercati
  2. Insiders
  3. Susan Galbraith